Enovis CORP
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.2 | $2.1 | $1.7 | $1.6 | $1.4 |
| Operating income | -$1.1 | -$0.8 | -$0.1 | -$0.1 | -$0.1 |
| Net income | -$1.2 | -$0.8 | -$<0.1 | -$<0.1 | $0.1 |
| Balance Sheet | |||||
| Total debt | $1.3 | $1.3 | $0.5 | $0.3 | $2.1 |
| Cash Flow Statement | |||||
| Free cash flow | $<0.1 | -$0.1 | $<0.1 | -$0.2 | $0.3 |
| Share repurchases | $<0.1 | $<0.1 | $0.0 | $0.0 | — |
Shares outstanding 57.7M · Free float 83.8%
Annual filing data through FY ended December 31, 2025; float as of September 10, 2026.
Earnings
Other Coverage
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
September 11, 2026
Insider Signal
GameStop Insiders Bought $21.7 Million of Stock
September 2, 2026
Deals
Enovis to Buy eCential Robotics in €155 Million Deal
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back